Navigation Links
Organization of cellular photosystems
Date:4/9/2014

A new DFG Research Unit funded will study the biogenesis of the complex membrane systems in which the light reactions of photosynthesis take place.

Professor Jrg Nickelsen of the Biocenter at Ludwig-Maximilians-Universitaet (LMU) in Munich will act as the official Speaker for the new Research Unit devoted to "Biogenesis of Thylakoid Membranes: Spatiotemporal Organization of Photosynthetic Protein Complex Assembly" and funded by the German Research Foundation (DFG). The venture has been approved by the DFG and will receive funding amounting to nearly 2 million euros. The interdisciplinary and multicenter network brings LMU scientists together with colleagues based in Bayreuth, Berlin, Bochum, Kaiserslautern and Potsdam to analyze the assembly of thylakoids. Thylakoids are membrane systems present in certain bacteria and in higher plants, which harbor the photosynthetic apparatus that converts solar radiation into chemical energy. "The new Research Unit represents a unique combination of expertise in molecular genetics, biochemistry, biophysics and structural analysis, allowing us to adopt a systematic approach to the analysis of the molecular details of the photosynthetic process," Nickelsen explains.

A complex interplay of multiple factors

By utilizing sunlight for the production of molecular oxygen and energy-rich organic compounds, photosynthesis provides the essential basis for all life on earth. Solar energy is captured by photoreactive molecules located in the thylakoids, and converted into a biochemically useful form in the so-called light reactions. Thylakoids are specialized membrane systems found in some bacterial species and in the chloroplasts of plant cells, and they are the most complicated type of biological energy-producing membranes known. Although their structure and function have been extensively investigated, little is known about how they are actually put together.

The assembly of thylakoids requires a c
'/>"/>

Contact: Luise Dirscherl
dirscherl@lmu.de
49-892-080-2706
Ludwig-Maximilians-Universitt Mnchen
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. New organization brings together top researchers to sequence the genomes of invertebrates
2. Unisys Security Experts Predict 2014 Will Be "The Year of Encryption" as Organizations Combat Growing Cyber Threats
3. New organization brings together top researchers to sequence genomes of invertebrates
4. UMass Amherst physics professor wins grant to study organization inside cells space
5. Join Leading Organizations at Biodetection Technologies 2013 in Alexandria, VA from June 18-19, 2013
6. Governor Corbett Presented 2013 Biotechnology Industry Organization Governor of the Year Award
7. Federal Government Organization achieves cleaner and faster Clinical Study Data using Tablet PCs from TabletKiosk
8. Japanese research organizations contribute to Human Brain Project
9. New look at cell membrane reveals surprising organization
10. Pan-European organizations call for an advanced understanding of the human brain
11. Algae Biomass Organization hails new UCSD study showing saltwater algae viable for biofuels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced that Huawei has selected the Synaptics ... its stylish smartwatch. Huawei chose the state-of-the-art ClearPad ... power and highly responsive human interface qualities such ... also required a classic round watch face and ...
(Date:7/27/2015)... , July 27, 2015   Zynx Health ... experience-based clinical improvement solutions, today announced that its ... now available on Android smartphones and tablets. With ... post-care organizations can use ZynxCarebook to securely exchange ... condition, streamline care transitions to other care settings, ...
(Date:7/23/2015)... July 23, 2015 Aware, Inc. (NASDAQ: AWRE ... reported financial results for its second quarter ended June 30, ... 2015 was $4.5 million, a decrease of 33% compared to ... in the second quarter of 2015 was $0.3 million, or ... $0.04 per diluted share, in the same period a year ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... Exceptionally long heat waves and other hot events could become ... according to a new study by Stanford University climate scientists. ... experiments, we see a clear emergence of much more intense, ... said Noah Diffenbaugh, an assistant professor of environmental Earth system ...
... you leave the pediatrician,s office if your child has ... different treatment. A novel application for applying DNA ... quickly and more accurately determine what,s causing a patient,s ... Mark R. Hartman, a Cornell University PhD candidate in ...
... Eurofins MWG Operon, an expert in next generation sequencing ... complex analysis and interpretation of such NGS data, announce ... to offer state-of-the art solutions for comprehensive genome analysis ... cooperate with a partner offering such a high level ...
Cached Biology News:Heat waves could be commonplace in the US by 2039, Stanford study finds 2Heat waves could be commonplace in the US by 2039, Stanford study finds 3Heat waves could be commonplace in the US by 2039, Stanford study finds 4Instant testing for sore throats wins CIMIT prize 2Instant testing for sore throats wins CIMIT prize 3Instant testing for sore throats wins CIMIT prize 4
(Date:7/28/2015)... 29, 2015 A ... rapidly developing and commercialising innovative medicines to transform ... Highly experienced management team; blue chip ... Mereo BioPharma Group Ltd ("Mereo"), a recently-formed speciality ... c. £76.5m), gross, from blue chip institutional investors and ...
(Date:7/28/2015)... 2015  PDL BioPharma, Inc. (PDL, or the Company) ... will release its second quarter 2015 financial results for ... 5, 2015, after market close. PDL,s management will host ... p.m. Eastern Time to discuss the financial results.  A ... via the webcast link on the PDL website. ...
(Date:7/28/2015)... ... July 28, 2015 , ... In terms of value, ... while production volume reached close to 1.84 million tonnes in the same year. ... 75.5% of the region’s total aluminium hydroxide production; the country’s aluminium hydroxide production ...
(Date:7/28/2015)... ... , ... VetStem Biopharma will be offering weekly private guided tours of our ... , The tour and course will be given every Wednesday at 6pm to local ... Staff members are welcome to attend with their veterinarian as well. Participants will be ...
Breaking Biology Technology:Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2
... LEXINGTON, Mass., Nov. 25 Indevus,Pharmaceuticals, Inc. (Nasdaq: ... fiscal year and the three-month period ended September,30, 2008. ... beginning,at 9:00 am eastern time (details follow below). , ... consolidated revenues of $77.8 million,an increase of 18% from fiscal ...
... Md., Nov. 25 EntreMed, Inc. (Nasdaq: ... the treatment of cancer and inflammatory diseases, announced today ... NYSSA 2008 Biotech and Specialty Pharmaceuticals Industry Conference, to ... New York, December 2, 2008. Dane R. Saglio, ...
... 24 Terumo Heart, Inc. is pleased to,announce the ... Executive,Officer (C.E.O.) and President, effective immediately. "With its innovative,mag-lev ... role in,the future treatment of heart failure. I am ... U.S. Pivotal trials in up to 40 clinical sites,and ...
Cached Biology Technology:Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 2Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 3Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 4Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 5Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 6Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 7Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 8Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 9Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 10Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results 11EntreMed to Present at the New York Society of Security Analysts Industry Conference 2Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President 2
... AquaMax DW4 liquid handling system from Molecular ... all in one instrument. The system handles ... and plate washing96-, 384- and 1536-welland is ... AquaMax DW4 has been optimized to dispense ...
... The Fluorescence Test Plate consists of ... format, with Inert Organic Fluorescent Compounds embedded ... be used on BioTeks FLx800 and Synergy ... ideal for GLP compliance while reducing the ...
... from the SMZ line is a Greenough stereomicroscope ... testing. It is available with a choice of ... space-saving compact base (N2GG). This microscope can be ... projector all at the same time giving you ...
... MATra-si Reagent optimized for siRNA applications, ... loaded with the nucleic acid of interest. ... dose is then rapidly drawn towards and ... efficient transfection. MATra-si Reagent can be used ...
Biology Products: